|
|
Volumn 24, Issue 9, 2003, Pages 291-299
|
|
Type 1: Diabetes millitus
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
AUTOANTIBODY;
GLUCOSE;
GLUTAMATE DECARBOXYLASE;
GLUTAMATE DECARBOXYLASE ANTIBODY;
HEAT SHOCK PROTEIN;
HEMOGLOBIN A1C;
IMMUNOGLOBULIN;
IMMUNOMODULATING AGENT;
INSULIN;
INSULIN ASPART;
INSULIN GLARGINE;
INSULIN LISPRO;
INSULIN PEPTIDE;
INSULIN ZINC SUSPENSION;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
ISOPHANE INSULIN;
MONOCLONAL ANTIBODY CD3;
MYCOPHENOLIC ACID;
NICOTINAMIDE;
OMEGA 3 FATTY ACID;
PANCREAS ISLET CELL ANTIBODY;
PEPTIDE DERIVATIVE;
RAPAMYCIN;
UNCLASSIFIED DRUG;
CHILDHOOD DISEASE;
CLINICAL EXAMINATION;
DIABETIC KETOACIDOSIS;
DOSE TIME EFFECT RELATION;
DRUG DELIVERY SYSTEM;
GLUCOSE BLOOD LEVEL;
HOME MONITORING;
HUMAN;
HYPERGLYCEMIA;
HYPOGLYCEMIA;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
KETONURIA;
OUTPATIENT;
PARENT COUNSELING;
PATHOGENESIS;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
REVIEW;
SCREENING;
TEAMWORK;
|
|
EID: 0041418368
PISSN: 01919601
EISSN: None
Source Type: Journal
DOI: 10.1542/pir.24-9-291 Document Type: Review |
|
Times cited : (18)
|
|
References (0)
|
